| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-084 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
1993-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a24ce68934ead89e277ab13f97fdc4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e051781a475ca6c0f9dc3e64de2c0108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4a960a620772ecbac6bc3c47b25f71a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c29ac28170d5f62231ae3ce137af068 |
| publicationDate |
1996-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5486453-A |
| titleOfInvention |
Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |
| abstract |
The present invention relates to polypeptides that immunologically mimic papillomavirus latent proteins and to antibodies and monoclonal antibodies that immunoreact with papillomavirus latent proteins. Systems and methods for detecting the presence and type of papillomavirus in a human subject are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011085231-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011085231-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015093742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113512109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021046114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011110965-A1 |
| priorityDate |
1988-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |